INHALEIQ — 2474533

Toolbar

Details

Application number

2474533

Type(s)

Standard Characters

Category

Trademark

CIPO Status

FORMALIZED

TM5 status

LIVE/APPLICATION/ Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.

Filed

2026-05-11

Applicant

MannKind Corporation
1 Casper Street
Danbury, CT 06810
UNITED STATES OF AMERICA

Agent

SMART & BIGGAR LP
Scotia Plaza, 40 King Street West
40th Floor
Toronto
ONTARIO M5H3Y2

Documents

Index headings

  • INHALEIQ
  • INHALE IQ

Goods (Nice class & Statement)

9
(1) Downloadable software in the nature of a mobile application for reading medical information and data from a medical device, for use by medical professionals and patients.
10
(2) Medical devices in the nature of inhalers, or inhaler accessory devices used to measure patient inhalation effort and to train patients in personal inhaler use; medical devices in the nature of inhalers, or inhaler accessory devices with features for measuring respiratory effort and facilitating the training of patients in use of inhalers; medical devices in the nature of inhalers, or inhaler accessory devices with features for the measurement of respiratory patterns of patients; medical devices included as a component of inhaler systems for medical use, namely, patient monitors for monitoring and measuring respiration; medical devices included as a component of inhaler systems for medical use, namely, devices used to indicate dosing of medication; medical devices included as a component of inhaler systems for medical use, namely, devices used to transmit and receive data regarding inhalation, respiration, or dosage.

Claims

  • Priority Filing Date: November 20, 2025, Country or Office: UNITED STATES OF AMERICA, Application No. 99/508,516 in association with the same kind of goods

Action History

Actions
Action Action date Due date Comments
Filed 2026-05-11
Created 2026-05-11
Formalized 2026-05-11
Date modified: